Daniel Javitt
Oprichter bij NeuroRx, Inc.
Vermogen: 4 M $ op 31-05-2024
Profiel
Daniel C.
Javitt is associated with NeuroRx, Inc. as a Co-Chairman since 2015.
He is the founder of NeuroRx, Inc. which was founded in 2015.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 29-04-2024 | 987 291 ( 9.23% ) | 4 M $ | 31-05-2024 |
Actieve functies van Daniel Javitt
| Bedrijven | Functie | Begin |
|---|---|---|
NeuroRx, Inc.
 NeuroRx, Inc. BiotechnologyHealth Technology NeuroRx, Inc. operates as a clinical stage, small molecule pharmaceutical company developing novel therapeutics for the treatment of central nervous system disorders. The company was founded by Jonathan C. Javitt and Daniel C. Javitt in 2015 and is headquartered in Wilmington, DE. | Oprichter | 01-01-2015 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
NeuroRx, Inc.
NeuroRx, Inc. BiotechnologyHealth Technology NeuroRx, Inc. operates as a clinical stage, small molecule pharmaceutical company developing novel therapeutics for the treatment of central nervous system disorders. The company was founded by Jonathan C. Javitt and Daniel C. Javitt in 2015 and is headquartered in Wilmington, DE. | Health Technology |
